Research news

Go to navigation
Go to content

The following shows headlines of all research-related news articles published within 12-months, starting from most recent.

Subscribe to RSS news feed

- Jul 23, 2008
- AstraZeneca and Bristol-Myers Squibb submit New Drug Application in the United States and Marketing Authorization Application in Europe for ONGLYZA™ (saxagliptin) for the treatment of type 2 diabetes
- Jun 17, 2008
- AstraZeneca and Columbia University Medical Center sign strategic research collaboration to develop novel therapeutics for diabetes and obesity
- Jun 7, 2008
- ONGLYZA™ (saxagliptin) demonstrated significant reductions in key measures of glucose control in treatment naïve people with type 2 diabetes
- May 27, 2008
- Study of twins reveals genetic susceptibility to COPD chronic obstructive pulmonary disease
- May 19, 2008
- New survey reveals Hispanic-Americans are taking steps to better understand and manage GERD
- Apr 17, 2008
- Washington University in St. Louis and AstraZeneca announce Alzheimer’s research collaboration
- Mar 12, 2008
- AstraZeneca completes enrollment in two pivotal Phase III studies of the investigational drug vandetanib (ZACTIMA®) in non-small cell lung cancer (NSCLC)
- Feb 27, 2008
- AstraZeneca provides update on cediranib (RECENTIN™, AZD2171) clinical development programme
- Jan 24, 2008
- M. D. Anderson Cancer Center and AstraZeneca form alliance to advance understanding of cancer-related neuropathic pain
- Dec 19, 2007
- AstraZeneca and Banner Alzheimer’s Institute collaborate to evaluate new tool targeting Alzheimer’s disease
- Nov 30, 2007
- AstraZeneca completes enrollment in first Phase III study of the investigational drug vandetanib (ZACTIMA®) in non-small cell lung cancer
- Sep 25, 2007
- Survival data presented from Phase II study of investigational drug ZD4054 in hormone resistant prostate cancer patients
- Sep 20, 2007
- Newly published Phase II study shows the investigational drug vandetanib prolongs progression-free survival in patients with advanced non-small cell lung cancer (NSCLC)

Page tools

Who is AstraZeneca?

Watch this short video to learn who we are and what we do